Ludwig M - Search Results

1

Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF.

Ludwig M, Albano C, Olivennes F, Felberbaum RE, Smitz J, Ortmann O, Romeis P, Niebch G, Pechstein B, Riethmüller-Winzen H, Devroey P, Diedrich K. Ludwig M, et al. Arch Gynecol Obstet. 2002 Jan;266(1):12-7. doi: 10.1007/pl00007490. Arch Gynecol Obstet. 2002. PMID: 11998957

2

[Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix].

Felberbaum RE, Ludwig M, Diedrich K. Felberbaum RE, et al. Among authors: ludwig m. Contracept Fertil Sex. 1999 Oct;27(10):701-9. Contracept Fertil Sex. 1999. PMID: 10605180 Clinical Trial. French.

3

No significant leukocytosis under controlled ovarian stimulation using the LHRH antagonist Cetrorelix and recFSH.

Ludwig M, Strik D, Felberbaum R, Al-Hasani S, Diedrich K. Ludwig M, et al. Eur J Obstet Gynecol Reprod Biol. 2000 Apr;89(2):177-9. doi: 10.1016/s0301-2115(99)00195-5. Eur J Obstet Gynecol Reprod Biol. 2000. PMID: 10725579 Clinical Trial.

4

Ovarian abscess and heterotopic triplet pregnancy: two complications after IVF in one patient.

Ludwig M, Felberbaum RE, Bauer O, Diedrich K. Ludwig M, et al. Arch Gynecol Obstet. 1999 Nov;263(1-2):25-8. doi: 10.1007/s004040050256. Arch Gynecol Obstet. 1999. PMID: 10728624

5

Serum leptin concentrations throughout the menstrual cycle.

Ludwig M, Klein HH, Diedrich K, Ortmann O. Ludwig M, et al. Arch Gynecol Obstet. 2000 Feb;263(3):99-101. doi: 10.1007/s004040050004. Arch Gynecol Obstet. 2000. PMID: 10763835

6

Deep vein thrombosis during administration of HMG for ovarian stimulation.

Ludwig M, Felberbaum RE, Diedrich K. Ludwig M, et al. Arch Gynecol Obstet. 2000 Feb;263(3):139-41. doi: 10.1007/s004040050014. Arch Gynecol Obstet. 2000. PMID: 10763845 Review.

7

Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study.

Felberbaum RE, Albano C, Ludwig M, Riethmüller-Winzen H, Grigat M, Devroey P, Diedrich K. Felberbaum RE, et al. Among authors: ludwig m. Hum Reprod. 2000 May;15(5):1015-20. doi: 10.1093/humrep/15.5.1015. Hum Reprod. 2000. PMID: 10783344 Clinical Trial.

8

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

Ludwig M, Felberbaum RE, Devroey P, Albano C, Riethmüller-Winzen H, Schüler A, Engel W, Diedrich K. Ludwig M, et al. Arch Gynecol Obstet. 2000 Jul;264(1):29-32. doi: 10.1007/pl00007479. Arch Gynecol Obstet. 2000. PMID: 10985616 Clinical Trial.

9

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix.

Ludwig M, Riethmüller-Winzen H, Felberbaum RE, Olivennes F, Albano C, Devroey P, Diedrich K. Ludwig M, et al. Fertil Steril. 2001 Jan;75(1):18-22. doi: 10.1016/s0015-0282(00)01632-0. Fertil Steril. 2001. PMID: 11163811 Free article.

10

Evaluation of an optimal luteal phase support protocol in IVF.

Ludwig M, Diedrich K. Ludwig M, et al. Acta Obstet Gynecol Scand. 2001 May;80(5):452-66. doi: 10.1034/j.1600-0412.2001.080005452.x. Acta Obstet Gynecol Scand. 2001. PMID: 11328224 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,336 results

Search Page

Filters